1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Highmark Corporate Giving / Grant & Sponsorship Online Application is sponsored by Highmark. Highmark's corporate giving program provides direct financial support to improve the quality of life and health and well-being in the communities they serve. They consider applications from programs and services that tie to their mission and have a compelling potential impact.
Get alerted about grants like this
Save a search for “Highmark” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Highmark Corporate Giving: Supporting Community Health and Programs Highmark Bright Blue Futures Highmark Bright Blue Futures Learn how we support the community health and programs. The decades-long legacy of Highmark includes direct financial support to improve the quality of life in the communities we serve. Today, our corporate giving benefits hundreds of organizations across our service area.
Grant & Sponsorship Requests We give preference to organizations that have a 501(c)(3) designation. Organizations that do not have that designation must provide their tax ID or EIN number to be considered for funding.
Corporate Giving Criteria We will consider applications from: Programs and services that tie to our mission and have a compelling potential impact to the health and well-being of individuals National organizations seeking support for local programs Grassroots and faith-based organizations We generally do not accept applications for or from: Capital or building campaigns Fraternal or civic groups Seed money for start-up organizations Requests for political causes or campaigns Grants, scholarships or sponsorships to individuals Highmark will not provide support to organizations that — in their constitution or practice discriminate against a person or group on the basis of the person's gender, race, color, age, religion, creed, ethnicity, national origin, disability, veteran or military status, marital status, sexual orientation/gender identity, genetic information or any other category protected by applicable federal, state or local law.
This statement addresses giving to a non-religious organization with an explicit policy of discrimination against Lesbian Gay Bisexual Transgender (LGBT) people. We review grant and sponsorship requests continuously and make awards throughout the year. Sponsorship requests must be made a minimum of 8 weeks prior to the decision deadline.
Please submit one application per calendar year. If you have multiple events in one year, we recommend including all requests in one application.
Visit this page for additional information on grant and/or sponsorship request processes: Delaware Blue Prints for the Community Highmark Blue Fund (Western NY) Highmark Blue Fund (Northeastern NY) Online Application Process Highmark has a web-based application process for all grant and sponsorship requests. Requests will be considered locally and reviewed for relevance in relation to our mission.
If your organization would like to request funding from Highmark, see our Grant & Sponsorship Online Application. General questions about our corporate giving can be directed to the Community Affairs department in your county. General questions about our corporate giving can be directed to the Community Affairs department in your county.
Non Discrimination Policy Electronic Data Interchange CMS’s Interoperability Rule Non Discrimination Policy Electronic Data Interchange CMS’s Interoperability Rule Network Access & Adequacy Network Access & Adequacy All references to “Highmark” in this document are references to the Highmark company that is providing the member’s health benefits or health benefit administration and/or to one or more of its affiliated Blue companies.
Highmark Blue Cross Blue Shield and Highmark Blue Shield are Medicare Advantage HMO, PPO, and/or Part D plans with a Medicare contract. Enrollment in these plans depends on contract renewal. Highmark Wholecare offers HMO plans with a Medicare Contract.
Enrollment in these plans depends on contract renewal. Highmark Health Options Duals offers HMO plans with a Medicare Contract. Enrollment in these plans depends on contract renewal.
®Blue Cross, Blue Shield and the Cross and Shield symbols are registered service marks of the Blue Cross Blue Shield Association, an association of independent Blue Cross and Blue Shield plans.
The following entities, which serve the noted regions, are independent licensees of the Blue Cross Blue Shield Association: Western and Northeastern PA: Highmark Inc. d/b/a Highmark Blue Cross Blue Shield, Highmark Choice Company, Highmark Health Insurance Company, Highmark Coverage Advantage Inc., Highmark Benefits Group Inc., First Priority Health, First Priority Life Insurance Company, Highmark Care Benefits Inc., Highmark Senior Health Company, or Gateway Health Plan, Inc. d/b/a Highmark Wholecare.
Central and Southeastern PA: Highmark Inc. d/b/a Highmark Blue Shield, Highmark Benefits Group Inc., Highmark Health Insurance Company, Highmark Choice Company, Highmark Senior Health Company, or Gateway Health Plan, Inc. d/b/a Highmark Wholecare. PA: Your plan may not cover all your health care expenses. Read your plan materials carefully to determine which health care services are covered.
For more information, call the number on the back of your member ID card or, if not a member, call 866-459-4418. Delaware: Highmark BCBSD Inc. d/b/a Highmark Blue Cross Blue Shield or Highmark BCBSD Health Options Inc. d/b/a Highmark Health Options. Highmark Health Options Duals is offered by Highmark Blue Cross Blue Shield.
West Virginia: Highmark West Virginia Inc. d/b/a Highmark Blue Cross Blue Shield, Highmark Health Insurance Company, Highmark Senior Solutions Company, or Highmark Health Options West Virginia Inc. d/b/a Highmark Health Options and Highmark Blue Cross Blue Shield. Highmark Health Options Duals is offered by Highmark Blue Cross Blue Shield. Visit https://www.
highmarkbcbswv. com/networkaccessplan to view the Access Plan required by the Health Benefit Plan Network Access and Adequacy Act. You may also request a copy by contacting us at the number on the back of your ID card.
Western NY: Highmark Western and Northeastern New York Inc. d/b/a Highmark Blue Cross Blue Shield. Northeastern NY: Highmark Western and Northeastern New York Inc. d/b/a Highmark Blue Shield.
Portal login or registration may be required to access the full application.
Based on current listing details, eligibility includes: Programs and services that align with Highmark's mission and demonstrate potential impact on the health and well-being of individuals. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Highmark BluePrints for the Community Small Grant is a grant from the Highmark Delaware Fund at the Delaware Community Foundation that funds nonprofit organizations and community-benefit government agencies serving Delaware residents. The program supports projects addressing health and wellness, community enrichment, and social needs for underserved populations in Delaware. Awards of up to $50,000 are available to incorporated 501(c)(3) nonprofits and eligible government agencies including libraries, parks, and public school districts. Eligible organizations must demonstrate a clear community benefit focus and a track record of effective programming. The 2026 application deadline was April 9, 2026. Highmark BluePrints grants are intended to support organizations making meaningful, measurable contributions to community health and quality of life in Delaware.
BluePrints for the Community grant program (Large Grants) is sponsored by Highmark Delaware Fund, a donor-advised fund at the Delaware Community Foundation. This program supports health-related projects, programs, and supportive services in Delaware, with a preference for initiatives that increase access to healthcare for uninsured/underserved, reduce health disparities, support early childhood development, recruit/train healthcare …
Corporate Giving (Health and Well-being) is sponsored by Highmark Inc.. Highmark Inc. provides corporate giving to programs and services that align with their mission and have a compelling potential impact on the health and well-being of individuals. This includes national organizations seeking support for local programs, as well as grassroots and faith-based organizations. They review grant and sponsorship requests continuously.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.